The intracellular sites of early replication and budding of SARS-coronavirus

被引:283
|
作者
Stertz, Silke
Reichelt, Mike
Spiegel, Martin
Kuri, Thomas
Martinez-Sobrido, Luis
Garcia-Sastre, Adolfo
Weber, Friedemann
Kochs, Georg [1 ]
机构
[1] Univ Freiburg, Dept Virol, D-79008 Freiburg, Germany
[2] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[3] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA
基金
美国国家卫生研究院;
关键词
SARS-coronavirus; replication; budding; double membrane vesicles;
D O I
10.1016/j.virol.2006.11.027
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In this study, we analyzed the replication and budding sites of severe acute respiratory syndrome coronavirus (SARS-CoV) at early time points of infection. We detected cytoplasmic accumulations containing the viral nucleocapsid protein, viral RNA and the non-structural protein nsp3. Using EM techniques, we found that these putative viral replication sites were associated with characteristic membrane tubules and double membrane vesicles that most probably originated from ER cisternae. In addition to its presence at the replication sites, N also accumulated in the Golgi region and colocalized with the viral spike protein. Immuno-EM revealed that budding occurred at membranes of the ERGIC (ER-Golgi intermediate compartment) and the Golgi region as early as 3 h post infection, demonstrating that SARS-CoV replicates surprisingly fast. Our data suggest that SARS-CoV establishes replication complexes at ER-derived membranes. Later on, viral nucleocapsids have to be transported to the budding sites in the Golgi region where the viral glycoproteins accumulate and particle formation occurs. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:304 / 315
页数:12
相关论文
共 50 条
  • [31] Immunological Responses against SARS-Coronavirus Infection in Humans
    Xu, Xiaojun
    Gao, Xiao-Ming
    CELLULAR & MOLECULAR IMMUNOLOGY, 2004, 1 (02) : 119 - 122
  • [32] Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients
    Shi, YL
    Wan, ZY
    Li, LH
    Li, P
    Li, CF
    Ma, QJ
    Cao, C
    JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (01) : 66 - 68
  • [33] Erratum to: Candidate Genes Associated with Susceptibility for SARS-Coronavirus
    Ying-Hen Hsieh
    Cathy W. S. Chen
    Shu-Fang Hsu Schmitz
    Chwan-Chuan King
    Wei-Ju Chen
    Yi-Chun Wu
    Mei-Shang Ho
    Bulletin of Mathematical Biology, 2010, 72 : 763 - 763
  • [34] Tracing SARS-coronavirus variant with large genomic deletion
    Chiu, RWK
    Chim, SSC
    Tong, YK
    Fung, KSC
    Chan, PKS
    Zhao, GP
    Lo, YMD
    EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 168 - 170
  • [35] In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation
    Bouvet, Mickael
    Debarnot, Claire
    Imbert, Isabelle
    Selisko, Barbara
    Snijder, Eric J.
    Canard, Bruno
    Decroly, Etienne
    PLOS PATHOGENS, 2010, 6 (04) : 1 - 13
  • [36] Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris
    Chi-Pang Chuck
    Chi-Hang Wong
    Larry Ming-Cheung Chow
    Kwok-Pui Fung
    Mary Miu-Yee Waye
    Stephen Kwok-Wing Tsui
    Virus Genes, 2009, 38 : 1 - 9
  • [37] Immunological Responses against SARS-Coronavirus Infection in Humans
    Xiaojun Xu Xiao-Ming Gao Department of Immunology
    Cellular&MolecularImmunology, 2004, (02) : 119 - 122
  • [38] Susceptibility of different eukaryotic cell lines to SARS-coronavirus
    K. Hattermann
    M. A. Müller
    A. Nitsche
    S. Wendt
    O. Donoso Mantke
    M. Niedrig
    Archives of Virology, 2005, 150 : 1023 - 1031
  • [39] The SARS-coronavirus nucleocapsid protein: A protein with multifarious activities
    Surjit, Milan
    Liu, Boping
    Chow, Vincent T. K.
    Lal, Sunil K.
    INFECTION GENETICS AND EVOLUTION, 2008, 8 (04) : S47 - S47
  • [40] Characterization of viral proteins encoded by the SARS-coronavirus genome
    Tan, YJ
    Lim, SG
    Hong, WJ
    ANTIVIRAL RESEARCH, 2005, 65 (02) : 69 - 78